Trade Sino Biopharmaceutical Limited - 1177 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.021963% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.000045% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.68 |
| Open | 2.68 |
| 1-Year Change | -35.58% |
| Day's Range | 2.68 - 2.74 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | 2.72 | 0.04 | 1.49% | 2.68 | 2.74 | 2.66 |
| Apr 25, 2024 | 2.68 | 0.08 | 3.08% | 2.60 | 2.74 | 2.60 |
| Apr 24, 2024 | 2.62 | 0.08 | 3.15% | 2.54 | 2.64 | 2.52 |
| Apr 23, 2024 | 2.50 | 0.02 | 0.81% | 2.48 | 2.56 | 2.46 |
| Apr 22, 2024 | 2.48 | 0.12 | 5.08% | 2.36 | 2.50 | 2.36 |
| Apr 19, 2024 | 2.28 | -0.08 | -3.39% | 2.36 | 2.36 | 2.24 |
| Apr 18, 2024 | 2.38 | -0.02 | -0.83% | 2.40 | 2.42 | 2.36 |
| Apr 17, 2024 | 2.40 | -0.08 | -3.23% | 2.48 | 2.50 | 2.38 |
| Apr 16, 2024 | 2.48 | -0.10 | -3.88% | 2.58 | 2.60 | 2.46 |
| Apr 15, 2024 | 2.62 | 0.00 | 0.00% | 2.62 | 2.64 | 2.58 |
| Apr 12, 2024 | 2.66 | -0.06 | -2.21% | 2.72 | 2.74 | 2.66 |
| Apr 11, 2024 | 2.72 | 0.00 | 0.00% | 2.72 | 2.76 | 2.70 |
| Apr 10, 2024 | 2.78 | -0.02 | -0.71% | 2.80 | 2.82 | 2.78 |
| Apr 9, 2024 | 2.78 | -0.04 | -1.42% | 2.82 | 2.84 | 2.78 |
| Apr 8, 2024 | 2.78 | 0.00 | 0.00% | 2.78 | 2.82 | 2.76 |
| Apr 5, 2024 | 2.76 | -0.04 | -1.43% | 2.80 | 2.82 | 2.72 |
| Apr 3, 2024 | 2.86 | -0.02 | -0.69% | 2.88 | 2.90 | 2.86 |
| Apr 2, 2024 | 2.90 | -0.02 | -0.68% | 2.92 | 2.96 | 2.88 |
| Mar 28, 2024 | 2.96 | 0.02 | 0.68% | 2.94 | 3.02 | 2.92 |
| Mar 27, 2024 | 2.96 | -0.06 | -1.99% | 3.02 | 3.04 | 2.96 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Sino Biopharmeceutical Company profile
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.| Industry: | Pharmaceuticals (NEC) |
湾仔港湾道1号会展广场辨公大楼41楼09室
HK
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com